RxDoctor Payments Data

Katherine Smith

Nurse Practitioner · Oxford, MSNPI 1215021001

Payments from drug & device makers

$987in general payments, 2019–2025

Across 55 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$294
  • Amarin Pharma, Inc.$112
  • Novo Nordisk$103
  • GRT US Holding, Inc.$80
  • Ironwood Pharmaceuticals, Inc$64
  • Boehringer Ingelheim$64
  • plus $270 from 9 others

What the payments were for

  • Food & beverage$987100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$987 in reported general payments places this provider in the 70th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$206
Medicare patients
15
Services billed
15

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast11$55,087
OzempicSemaglutide47$49,103
FarxigaDapagliflozin Propanediol35$19,479
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr30$18,995
TrulicityDulaglutide15$17,956
EliquisApixaban21$17,141
LinzessLinaclotide14$15,067
JardianceEmpagliflozin20$14,224
Tresiba Flextouch U-100Insulin Degludec12$7,157
Dexlansoprazole DrDexlansoprazole17$3,594
Novolog FlexpenInsulin Aspart15$2,591
Albuterol Sulfate HfaAlbuterol Sulfate50$1,685
Gabapentin136$947
Potassium Chloride83$864
Amiodarone Hcl14$863

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$103$49,10347 claims
GSKAnoro Ellipta$15$18,99530 claims
Lilly USA, LLCTrulicity$46$17,95615 claims
PfizerEliquis$35$17,14121 claims
AbbVieLinzess$294$15,06714 claims
Boehringer IngelheimJardiance$64$14,22420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Oxford

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →